Mustafa Onmaz

Mustafa Onmaz is currently a Lecturer at the Department of Internal Medical Sciences, Faculty of Medicine, Bandırma Onyedi Eylül University (2025–Ongoing). His academic work focuses on biochemical markers in autoimmune and chronic diseases, with a particular emphasis on mass spectrometry applications in clinical diagnostics. He has contributed to methodological advancements in drug quantification (e.g., hydroxychloroquine and favipiravir) and explored metabolic pathways linked to conditions like systemic lupus erythematosus and rheumatoid arthritis. His research also addresses public health topics such as smoking-related biomarkers and prostate cancer screening behaviors.

Key contributions include co-authoring a chapter in CURRENT STUDIES IN MEDICAL BIOCHEMISTRY (2024) and leading a BAP-funded project on cigarette smoking’s effects on serum biomarkers (2021–2022). His recent publications span journals like Elsevier BV, Springer, and Turkish Journal of Biochemistry. Notably, his work combines clinical biochemistry with analytical techniques to improve disease understanding and therapeutic strategies.

No scientific awards are explicitly listed in the provided data. His advising and grants include directing a research project and contributing to collaborative studies in medical biochemistry. While no lab affiliations are detailed, his involvement in biochemical research groups is implied through his methodological and clinical studies.